metoclopramide has been researched along with physostigmine in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (30.77) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Fuchs, HF; Maeder, HU | 1 |
| Chee, KY; Sachdev, P | 1 |
| Bresadola, F; Caria, MA; Mameli, O; Melis, F; Muretti, P; Soro, P; Tolu, E | 1 |
| Buyniski, JP; Gidda, JS | 1 |
| Helmreich, I; Hertting, G; Reimann, W; Starke, K | 1 |
| Bianco, AC; Kimura, ET; Monte, O; Zyngier, S | 1 |
| Hasan, MY; Kuča, K; Lorke, DE; Nurulain, SM; Petroianu, GA; Shafiullah, M | 1 |
1 review(s) available for metoclopramide and physostigmine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for metoclopramide and physostigmine
| Article | Year |
|---|---|
Pharmacological characterization of tardive akathisia.
Topics: Administration, Oral; Aged; Akathisia, Drug-Induced; Antipsychotic Agents; Arousal; Atenolol; Benztropine; Brain; Bromocriptine; Chronic Disease; Clonidine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Dyskinesia, Drug-Induced; Humans; Infusions, Intravenous; Male; Metoclopramide; Metoprolol; Physostigmine; Propranolol; Psychomotor Agitation; Schizophrenia, Paranoid | 1990 |
11 other study(ies) available for metoclopramide and physostigmine
| Article | Year |
|---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
[Pharmacoradiography of the gastro intestinal tract (author's transl)].
Topics: Atropine; Butylscopolammonium Bromide; Gastrointestinal Diseases; Gastrointestinal Motility; Glucagon; Humans; Metoclopramide; Morphine; Oxyphenonium; Parasympatholytics; Physostigmine; Propantheline; Radiography | 1976 |
Physostigmine and metoclopramide in oesophageal peristaltic spread in man.
Topics: Electrodes; Esophagus; Humans; Metoclopramide; Peristalsis; Physostigmine | 1988 |
Swallow-evoked peristalsis in opossum esophagus: role of cholinergic mechanisms.
Topics: Animals; Atropine; Deglutition; Esophagus; Evoked Potentials; Female; Gastrointestinal Motility; Male; Metoclopramide; Muscle Contraction; Muscle, Smooth; Opossums; Peristalsis; Physostigmine | 1986 |
Are presynaptic dopamine autoreceptors and postsynaptic dopamine receptors in the rabbit caudate nucleus pharmacologically different?
Topics: Acetylcholine; Animals; Apomorphine; Atropine; Carbachol; Caudate Nucleus; Choline; Dopamine; Electric Stimulation; Female; Male; Membrane Potentials; Metoclopramide; Molindone; Physostigmine; Rabbits; Receptors, Dopamine; Sulpiride; Synapses; Synaptic Transmission | 1982 |
[Dopaminergic and somatostatinergic pathways decrease serum thyrotropin in rats bearing the 256-Walker mammary carcinoma].
Topics: Animals; Carcinoma 256, Walker; Dopamine; Euthyroid Sick Syndromes; Hypothalamo-Hypophyseal System; Male; Mammary Neoplasms, Experimental; Metoclopramide; Physostigmine; Rats; Rats, Sprague-Dawley; Somatostatin; Thyroid Gland; Thyroid Hormones; Thyrotropin; Thyrotropin-Releasing Hormone | 2005 |
Pretreatment for acute exposure to diisopropylfluorophosphate: in vivo efficacy of various acetylcholinesterase inhibitors.
Topics: Amiloride; Animals; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Erythrocytes; Female; Humans; Inhibitory Concentration 50; Isoflurophate; Male; Methylene Blue; Metoclopramide; Oximes; Physostigmine; Proportional Hazards Models; Pyridinium Compounds; Pyridostigmine Bromide; Ranitidine; Rats; Tacrine; Tiapride Hydrochloride | 2011 |